Pfizer supplies cheap drugs to 45 low-income countries


Pfizer joins the “Agreement for a Healthier World” to help improve health equity for 1.2 billion people in 45 low-income countries. The agreement focuses on five areas: infectious diseases, cancer, inflammatory diseases, rare diseases and women’s health.

Albert Bourla, President and CEO of Pfizer, said the agreement will close the health equality gap, helping to create a healthier world.

“We will work closely with global health leaders to make improvements in diagnostics, education, infrastructure, storage and more. Only when we get through all of the challenges. obstacles, only then can we end inequality in health care and provide it to all patients,” said Albert Bourla.

Participating in this agreement are all 27 low-income countries and 18 low-middle income countries. In which, Rwanda, Ghana, Malawi, Senegal and Uganda are the first 5 countries to commit to join the agreement. Health officials in these five countries will help address barriers including beyond availability.

Pharmaceutical company Pfizer (USA) wants to sell cheap drugs to 45 poor countries. Photo: Pfizer

Pursuant to the agreement, Pfizer has committed to supply 23 drugs and vaccines for the treatment of infectious diseases, certain cancers, rare diseases and diseases related to the inflammatory process.

Pfizer’s drugs and vaccines are sold at “non-profit” prices, which keep manufacturing and shipping costs to a minimum. Countries participating in the agreement will buy back at a cheaper price than other countries.

In addition to those already available, Pfizer is promoting the development of vaccines to prevent group B strep disease (GBS), with funding from the Bill & Melinda Gates Foundation. It is a leading cause of stillbirth and infant mortality in low-income countries.

Pfizer is also discussing opportunities to support the development of a respiratory syncytial virus (RSV) vaccine, another vaccine for pregnant women.



Leave a Reply

Your email address will not be published. Required fields are marked *